DK0806952T3 - Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger - Google Patents

Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger

Info

Publication number
DK0806952T3
DK0806952T3 DK95919986T DK95919986T DK0806952T3 DK 0806952 T3 DK0806952 T3 DK 0806952T3 DK 95919986 T DK95919986 T DK 95919986T DK 95919986 T DK95919986 T DK 95919986T DK 0806952 T3 DK0806952 T3 DK 0806952T3
Authority
DK
Denmark
Prior art keywords
treatment
drugs
manufacture
uterine bleeding
dysfunctional uterine
Prior art date
Application number
DK95919986T
Other languages
Danish (da)
English (en)
Inventor
Kristof Chwalisz
Klaus Stoeckemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0806952T3 publication Critical patent/DK0806952T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95919986T 1995-02-02 1995-02-02 Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger DK0806952T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1995/000394 WO1996023503A1 (de) 1995-02-02 1995-02-02 Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen

Publications (1)

Publication Number Publication Date
DK0806952T3 true DK0806952T3 (da) 2003-06-16

Family

ID=8165951

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95919986T DK0806952T3 (da) 1995-02-02 1995-02-02 Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger

Country Status (20)

Country Link
US (1) US6451780B1 (fi)
EP (1) EP0806952B1 (fi)
JP (1) JPH10512889A (fi)
KR (1) KR100370908B1 (fi)
AT (1) ATE235907T1 (fi)
AU (1) AU714959B2 (fi)
CA (1) CA2186953C (fi)
DE (1) DE59510626D1 (fi)
DK (1) DK0806952T3 (fi)
ES (1) ES2196063T3 (fi)
FI (1) FI117850B (fi)
HU (1) HU226276B1 (fi)
MX (1) MX9603889A (fi)
NO (1) NO964155D0 (fi)
NZ (1) NZ287024A (fi)
PL (1) PL316533A1 (fi)
PT (1) PT806952E (fi)
SK (1) SK282570B6 (fi)
UA (1) UA37259C2 (fi)
WO (1) WO1996023503A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193252B1 (en) * 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
KR100864547B1 (ko) 1999-08-31 2008-10-20 바이엘 쉐링 파마 악티엔게젤샤프트 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
US6685626B2 (en) 2001-02-02 2004-02-03 Regeneration Technologies, Inc. Compositions, devices, methods, and kits for induction of adhesions
US20020176893A1 (en) * 2001-02-02 2002-11-28 Wironen John F. Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7556150B2 (en) * 2004-06-07 2009-07-07 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of DUB
WO2007103510A2 (en) * 2006-03-08 2007-09-13 Danco Laboratories Llc Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders
EP2148681B1 (en) 2007-04-20 2016-03-16 PregLem S.A. Selective progesterone modulators in the treatment of uterine bleeding
WO2009061569A1 (en) * 2007-11-05 2009-05-14 Repros Therapeutics Inc. Compositions and methods for treating dysfunctional uterine bleeding
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
EP2545922A1 (en) * 2011-07-12 2013-01-16 PregLem S.A. Treatment of excessive menstrual bleeding associated with uterine fibroids
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
AU2013338305B2 (en) 2012-11-02 2018-06-07 Allergan pharmaceuticals International Ltd. Methods and compositions for treating progesterone-dependent conditions
EP3394079A4 (en) 2015-12-23 2019-08-21 Oric Pharmaceuticals, Inc. INHIBITORS OF GLUCOCORTICOIDREZEPTORS
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CN108699102A (zh) 2015-12-23 2018-10-23 欧瑞克制药公司 糖皮质激素受体抑制剂
ES2867853T3 (es) 2016-10-07 2021-10-21 Oric Pharmaceuticals Inc Inhibidor del receptor de glucocorticoides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622943A (en) 1992-05-06 1997-04-22 The Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding

Also Published As

Publication number Publication date
SK282570B6 (sk) 2002-10-08
ES2196063T3 (es) 2003-12-16
NO964155L (no) 1996-10-01
NO964155D0 (no) 1996-10-01
FI963049A0 (fi) 1996-08-01
KR100370908B1 (ko) 2003-04-10
PT806952E (pt) 2003-08-29
MX9603889A (es) 1997-04-30
UA37259C2 (uk) 2001-05-15
WO1996023503A1 (de) 1996-08-08
ATE235907T1 (de) 2003-04-15
AU2561195A (en) 1996-08-21
HU226276B1 (en) 2008-07-28
FI963049A (fi) 1996-10-01
US6451780B1 (en) 2002-09-17
FI117850B (fi) 2007-03-30
EP0806952B1 (de) 2003-04-02
SK121996A3 (en) 1997-05-07
CA2186953C (en) 2009-11-10
HU9602668D0 (en) 1996-11-28
EP0806952A1 (de) 1997-11-19
KR970704451A (ko) 1997-09-06
NZ287024A (en) 2001-03-30
DE59510626D1 (de) 2003-05-08
CA2186953A1 (en) 1996-08-08
AU714959B2 (en) 2000-01-13
PL316533A1 (en) 1997-01-20
HUT75930A (en) 1997-05-28
JPH10512889A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
DK0806952T3 (da) Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
DE69531998D1 (de) Steroidrezeptor-modulator verbindungen und methoden
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
NO994850L (no) Farmakologiske midler
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
YU7797A (sh) Kombinovana terapija za osteoporozu
ATE398630T1 (de) Zyklische conotoxin-peptide
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
NO164656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin.
PT1140031E (pt) Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
PT1066304E (pt) Antagonistas macrolidos de lhrh
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
DK0814803T3 (da) Anvendelse af steroidale estrogenreceptorantagonister til fertilitetskontrol hos mænd
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
SE9803277D0 (sv) Novel compounds
NO862648L (no) Framgangsmÿte for framstilling av farmakologisk aktive 2-substituerte-3,4-dihydroksyfenyletylamino-derivater.
NO912497D0 (no) Doseringsform for administrering av kalsiumantagonist.